You have 9 free searches left this month | for more free features.

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)

Withdrawn
  • Stage II Renal Cell Cancer
  • Stage III Renal Cell Cancer
  • (no location specified)
Aug 11, 2022

Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma Trial in Worldwide (Nelarabine, Etoposide,

Terminated
  • Relapsed T-Cell Acute Lymphoblastic Leukemia
  • Relapsed T-Cell Lymphoblastic Lymphoma
  • Los Angeles, California
  • +36 more
Sep 8, 2020

Delirium in Children Undergoing Stem Cell Transplantation

Recruiting
  • Stem Cell Transplant Complications
  • Delirium
  • Daily screening for delirium
  • San Francisco, California
  • +5 more
Sep 13, 2022

Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

Recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Gingival Recession Trial in Rohtak (Periodontal plastic surgery procedure and orthodontic treatment, Periodontal plastic surgery

Completed
  • Gingival Recession
  • Periodontal plastic surgery procedure and orthodontic treatment
  • Periodontal plastic surgery procedure
  • Rohtak, Haryana, India
    Post Graduate Institute of Dental Sciences
Aug 19, 2022

NSCLC Trial in Hangzhou, Nanjing (IBI308, Docetaxel)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 1, 2021

Plaque Psoriasis Trial in Russian Federation (Adalimumab, Humira)

Not yet recruiting
  • Plaque Psoriasis
  • Barnaul, Russian Federation
  • +8 more
Aug 21, 2023

Toxicity, Drug Trial in Hefei (neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery)

Recruiting
  • Toxicity, Drug
  • neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery
  • Hefei, Anhui, China
    Anhui Provicial Hospital
May 1, 2022

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Pediatric Patients With Cystic Fibrosis in Sohag.

Recruiting
  • Cystic Fibrosis
  • sweat chloride test
  • genetic testing
  • Sohag, Egypt
    Sohag University Hospital
Dec 29, 2022

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Chronic Low-back Pain Trial in Famagusta (Instrument Assisted Soft Tissue Mobilization Group While Lying Prone, Instrument

Not yet recruiting
  • Chronic Low-back Pain
  • Instrument Assisted Soft Tissue Mobilization Group While Lying Prone
  • Instrument Assisted Soft Tissue Mobilization Group Combined with Functional Movement
  • Famagusta, Cyprus
    Süleyman Güzelşemme
Nov 14, 2022

Low Back Pain Trial in Natal (Exercises and dry cupping)

Not yet recruiting
  • Low Back Pain
  • Exercises and dry cupping
  • Natal, RN, Brazil
    Marcelo Cardoso de Souza
Jul 13, 2022

Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

Not yet recruiting
  • T-Cell Lymphoma
  • No intervention
  • Bordeaux, France
  • +10 more
May 24, 2023

Alzheimer Trial in Leuven, Wilrijk (11C-JNJ-63779586)

Completed
  • Alzheimer Disease
  • Leuven, Belgium
  • +1 more
Dec 7, 2021

Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

Recruiting
  • Pediatric Sarcoma, Refractory
  • Pediatric Sarcoma, Relapsed
  • GEM/DOX + TGFBi expanded NK cells
  • Tampa, Florida
  • +1 more
Jan 3, 2023

Refractory Diffuse Large B-cell Lymphoma Trial (Rituximab Paclitaxel Ruxolitinib)

Not yet recruiting
  • Refractory Diffuse Large B-cell Lymphoma
  • Rituximab Paclitaxel Ruxolitinib
  • (no location specified)
Apr 19, 2021

Celiac Disease in Children, Type 1 Diabetes, Thyroid Trial in Malmö (Probiotic, Placebo)

Recruiting
  • Celiac Disease in Children
  • +2 more
  • Probiotic
  • Placebo
  • Malmö, Sweden
    Clinical Research Center (CRC), Bldng 60:11
Apr 5, 2022

Mental Health Trial in United States (Implementation Facilitation, Centralized Technical Assistance)

Recruiting
  • Mental Health
  • Implementation Facilitation
  • Centralized Technical Assistance
  • Palo Alto, California
  • +8 more
Aug 11, 2023

Bone Marrow Biopsy Procedure Trial in Milwaukee (Ultrasound-assisted bone marrow biopsy, Landmark palpation bone marrow biopsy)

Recruiting
  • Bone Marrow Biopsy Procedure
  • Ultrasound-assisted bone marrow biopsy
  • Landmark palpation bone marrow biopsy
  • Milwaukee, Wisconsin
    Froedtert Hospital
May 19, 2022

Chronic Pain, Arthritis Hand, Opioid Use Trial in San Diego (Standard of care, Nottingham AR smartphone app with active

Recruiting
  • Chronic Pain
  • +2 more
  • Standard of care
  • Nottingham AR smartphone app with active intervention
  • San Diego, California
    VA San Diego Healthcare System
Dec 5, 2022

Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)

Recruiting
  • Moderate-to-Severe Plaque Psoriasis
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of China Medical University
Nov 28, 2022

Factors in Patients With Primary Central Nervous System Lymphoma

Recruiting
  • PCNSL
  • Survival Analysis
  • prognostic marker
  • Zhengzhou, Henan, China
    Zhengzhou university
Dec 12, 2021

Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Heart Failure
  • +3 more
  • Empagliflozin 10 MG
  • Placebo
  • (no location specified)
Sep 20, 2023